Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...

Investigators found a consistent relationship between physical activity and both fatigue and QoL. Patients with little or no ...

MoonLake says FDA may allow approval filing for its HS drug Sonelokimab without new trials after strong study results, keeping its 2026 submission plans on track.

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License ...